Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (584)

1

Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma : A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von De La Fouchardière, C. | Malka, D. | Cropet, C. | +23

2

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Albain, K. | Yau, C. | Petricoin, E. | +46

3

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3) : Final overall survival results from a randomized phase 3 trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Diéras, V. | Han, H. | Wildiers, H. | +8

4

A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)

enthalten in: Cancer cell | 2024

von Zhou, C. | Hu, Y. | Arkania, E. | +24

CommentIn: Cancer Cell. 2024 Feb 12;42(2):172-174. - PMID 38350419

5

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases : A Randomized Phase III Clinical Trial (HIPECOVA)

enthalten in: Current oncology (Toronto, Ont.) | 2024

von Villarejo Campos, P. | Sánchez García, S. | Amo-Salas, M. | +6

6

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer : The Phase III DUO-E Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Westin, S. | Moore, K. | Chon, H. | +128

7

Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer : Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Arend, R. | Monk, B. | Shapira-Frommer, R. | +89

8

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer : a randomized phase 3 trial

enthalten in: Nature medicine | 2024

von Jiang, Z. | Ouyang, Q. | Sun, T. | +55

9

Lunchbox trial : A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma

enthalten in: Gynecologic oncology | 2024

von Barlin, J. | Mahar, B. | Ata, A. | +14

10

AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer : a multicenter randomized phase III trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Heitz, F. | Marth, C. | Henry, S. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[59]